KRAS and germ cell tumor: LP-WGS of the plasma sample at diagnosis (Fig. 4a) prior to initiation of chemotherapy showed a highly complex pattern of whole chromosome and segmental gains and losses, including a gain of 12p and amplification of a region in 12q that included KRAS, alterations that are characteristic for germ cell tumor.